These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 8769166

  • 1. Chronic cyclosporine nephropathy in renal transplantation.
    Bennett WM, DeMattos A, Meyer MM, Andoh T, Barry JM.
    Transplant Proc; 1996 Aug; 28(4):2100-3. PubMed ID: 8769166
    [No Abstract] [Full Text] [Related]

  • 2. Protocol core biopsy as intermediate efficacy end-point in chronic kidney allograft rejection.
    Yilmaz S, Taskinen E, Häyry P, Isoniemi H.
    Transplant Proc; 1996 Feb; 28(1):491-3. PubMed ID: 8644324
    [No Abstract] [Full Text] [Related]

  • 3. Morphological criteria of chronic rejection: differential diagnosis, including cyclosporine nephropathy.
    Mihatsch MJ, Ryffel B, Gudat F.
    Transplant Proc; 1993 Apr; 25(2):2031-7. PubMed ID: 8470264
    [No Abstract] [Full Text] [Related]

  • 4. Long-term effects of chronic cyclosporine nephropathy on outcome of renal allografts.
    Takeda A, Morozumi K, Haba T, Katayama A, Tominaga Y, Uchida K.
    Transplant Proc; 2001 Apr; 33(7-8):3379-80. PubMed ID: 11750445
    [No Abstract] [Full Text] [Related]

  • 5. Immunologic and nonimmunologic contributors to glomerular segmental sclerosis in renal transplantation.
    Jeong HJ, Kim YS, Oh CK, Park K, Choi IJ.
    Transplant Proc; 1996 Jun; 28(3):1224-5. PubMed ID: 8658635
    [No Abstract] [Full Text] [Related]

  • 6. Follow-up of patients with borderline changes in renal allograft biopsies: clinical outcome and evaluation of other histological features in addition to tubulitis.
    Papadimitriou J, Drachenberg C, Anderson L, Bartlett S, Johnson L, Klassen D, Hoehn-Saric E, Weir M, Schweitzer E.
    Transplant Proc; 1996 Feb; 28(1):517-8. PubMed ID: 8644334
    [No Abstract] [Full Text] [Related]

  • 7. Influence of renal mass on chronic kidney allograft rejection in rats.
    Heemann UW, Azuma H, Tullius SG, Mackenzie HS, Schmid C, Brenner BM, Tilney NL.
    Transplant Proc; 1995 Feb; 27(1):549. PubMed ID: 7879094
    [No Abstract] [Full Text] [Related]

  • 8. The differential diagnosis between rejection and cyclosporine toxicity.
    Mihatsch MJ, Ryffel B, Gudat F.
    Kidney Int Suppl; 1995 Dec; 52():S63-9. PubMed ID: 8587287
    [No Abstract] [Full Text] [Related]

  • 9. [Spontaneous proliferative response in patients with chronic renal allograft insufficiency due to chronic rejection].
    Savin M, Ramić Z, Mostarica-StojkovićM, Djukanović Lj.
    Srp Arh Celok Lek; 1994 Dec; 122(5-6):142-5. PubMed ID: 17977411
    [Abstract] [Full Text] [Related]

  • 10. Magnetic resonance imaging in assessment of rejection of a kidney allograft in the rat: effect of the somatostatin analogue SMS 201-995.
    Schuurman HJ, Beckmann N, Briner U, Bruns C, Bruttel K, Tanner M, Tolcsvai L, Weckbecker G.
    Transplant Proc; 1996 Dec; 28(6):3272-5. PubMed ID: 8962271
    [No Abstract] [Full Text] [Related]

  • 11. Early conversion from cyclosporine to tacrolimus increases renal graft function in chronic allograft nephropathy at BANFF stages I and II.
    Marcard T, Ivens K, Grabensee B, Willers R, Helmchen U, Rump LC, Blume C.
    Transpl Int; 2008 Dec; 21(12):1153-62. PubMed ID: 18684111
    [Abstract] [Full Text] [Related]

  • 12. Is sirolimus a safe alternative to reduce or eliminate calcineurin inhibitors in chronic allograft nephropathy in kidney transplantation?
    Lai WJ, Chiang YJ, Chen Y, Chu SH.
    Transplant Proc; 2004 Sep; 36(7):2056-7. PubMed ID: 15518744
    [Abstract] [Full Text] [Related]

  • 13. The value of electron microscopy in the diagnosis of chronic renal allograft rejection.
    Ivanyi B, Kemeny E, Szederkenyi E, Marofka F, Szenohradszky P.
    Mod Pathol; 2001 Dec; 14(12):1200-8. PubMed ID: 11743041
    [Abstract] [Full Text] [Related]

  • 14. Changes in urinary interleukin-2 in kidney transplant recipients.
    Kumano K, Irie A, Mashimo S, Endo T, Koshiba K.
    Transplant Proc; 1996 Jun; 28(3):1248-9. PubMed ID: 8658644
    [No Abstract] [Full Text] [Related]

  • 15. Renal transplant histopathologic changes during the first year in patients with tacrolimus (FK 506).
    Wilczek HE, Brattström C, Reinholt FP, Tydén G, Ericzon BG.
    Transplant Proc; 1996 Dec; 28(6):3177. PubMed ID: 8962232
    [No Abstract] [Full Text] [Related]

  • 16. Severe cyclosporine arteriolopathy with focal segmental glomerulosclerosis is not a fatal finding in chronic renal allograft failure after year 5 of transplantation using cyclosporine.
    Takeda A, Morozumi K, Koyama K, Yoshida A, Uchida K, Tominaga Y, Haba T, Oikawa T, Usami T, Sugito K, Takeuchi O, Fujinami T, Yokoyama I, Takagi H.
    Transplant Proc; 1997 Dec; 29(1-2):96-9. PubMed ID: 9123169
    [No Abstract] [Full Text] [Related]

  • 17. Proteinuria after renal allograft: assessment based on severity and causes.
    Jeong HJ, Kim YS, Oh CK, Park K, Choi IJ.
    Transplant Proc; 1994 Aug; 26(4):2132-3. PubMed ID: 8066695
    [No Abstract] [Full Text] [Related]

  • 18. Safety and tolerability of Neoral vs Sandimmune: 1-year data in primary renal allograft recipients. Neoral Study Group.
    Barone G, Bunke CM, Choc MG, Hricik DE, Jin JH, Klein JB, Marsh CL, Min DI, Pescovitz MD, Pollak R, Pruett TL, Stinson JB, Thompson JS, Vasquez E, Waid T, Wombolt DG, Wong RL.
    Transplant Proc; 1996 Aug; 28(4):2183-6. PubMed ID: 8769194
    [No Abstract] [Full Text] [Related]

  • 19. Early cyclosporine a withdrawal in kidney-transplant recipients receiving sirolimus prevents progression of chronic pathologic allograft lesions.
    Goldfarb DA.
    J Urol; 2005 Jun; 173(6):2106-7. PubMed ID: 15879857
    [No Abstract] [Full Text] [Related]

  • 20. Impact of cyclosporine on chronic rejection and graft vasculopathy.
    Vanrenterghem Y, Peeters J.
    Transplant Proc; 1994 Oct; 26(5):2560-3. PubMed ID: 7940791
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.